SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.482
AS - Asia 5.553
EU - Europa 3.619
SA - Sud America 774
AF - Africa 115
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 10
Totale 24.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.979
SG - Singapore 2.117
CN - Cina 1.432
DE - Germania 843
IT - Italia 659
VN - Vietnam 616
BR - Brasile 586
UA - Ucraina 522
GB - Regno Unito 439
HK - Hong Kong 378
FI - Finlandia 342
TR - Turchia 327
CA - Canada 261
FR - Francia 195
RU - Federazione Russa 165
BD - Bangladesh 158
SE - Svezia 141
IN - India 123
JP - Giappone 117
MX - Messico 72
PL - Polonia 69
ZA - Sudafrica 48
AR - Argentina 47
NL - Olanda 47
BE - Belgio 41
ES - Italia 41
IQ - Iraq 40
CO - Colombia 35
ID - Indonesia 31
PK - Pakistan 31
LT - Lituania 29
EC - Ecuador 27
IL - Israele 27
HN - Honduras 25
VE - Venezuela 25
CR - Costa Rica 22
UZ - Uzbekistan 21
JM - Giamaica 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 18
MA - Marocco 18
MY - Malesia 18
SV - El Salvador 18
CL - Cile 16
CZ - Repubblica Ceca 16
PR - Porto Rico 16
TT - Trinidad e Tobago 16
GT - Guatemala 15
PH - Filippine 15
NI - Nicaragua 14
PY - Paraguay 12
TN - Tunisia 11
PE - Perù 10
AT - Austria 9
GP - Guadalupe 9
NP - Nepal 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
CH - Svizzera 7
IE - Irlanda 7
IR - Iran 7
JO - Giordania 7
CW - ???statistics.table.value.countryCode.CW??? 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KE - Kenya 6
KZ - Kazakistan 6
TH - Thailandia 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
KR - Corea 5
RO - Romania 5
ET - Etiopia 4
HR - Croazia 4
SC - Seychelles 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
DK - Danimarca 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
AM - Armenia 2
BB - Barbados 2
BJ - Benin 2
CY - Cipro 2
EE - Estonia 2
GD - Grenada 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
Totale 24.538
Salva come PNG Salva come JPEG
Città #
Ashburn 1.825
Singapore 1.408
Fairfield 1.156
Woodbridge 1.108
San Jose 779
Houston 683
Jacksonville 580
Ann Arbor 564
Chandler 513
Santa Clara 488
Seattle 455
Beijing 454
Wilmington 411
Council Bluffs 381
Cambridge 379
Hong Kong 373
Munich 340
Dallas 303
Los Angeles 287
New York 274
Ho Chi Minh City 204
Izmir 185
Helsinki 155
Nanjing 154
Milan 152
Hanoi 134
Princeton 115
Tokyo 113
San Diego 104
Boardman 101
Lauterbourg 97
Shanghai 91
Orem 80
Denver 79
Brooklyn 76
São Paulo 75
Montreal 74
Turku 72
Atlanta 68
London 67
Ferrara 61
Nanchang 61
Phoenix 60
Toronto 59
Warsaw 58
Chicago 56
Dearborn 55
Buffalo 50
Shenyang 47
Frankfurt am Main 46
San Francisco 46
Rome 43
Boston 39
Mexico City 39
Brussels 38
Hebei 35
Bremen 34
Falkenstein 33
Tianjin 33
Chennai 30
Da Nang 29
Hefei 29
Johannesburg 28
North Bergen 28
Manchester 26
Auburn Hills 25
Haiphong 25
Stockholm 25
Jiaxing 24
Mountain View 24
Philadelphia 24
San Mateo 24
Rio de Janeiro 23
Dhaka 22
Falls Church 22
Mcallen 22
Norwalk 22
The Dalles 22
Bologna 21
Amsterdam 20
Tashkent 20
Changsha 19
Mumbai 19
San José 19
Baghdad 18
Calgary 18
Jinan 18
Moscow 18
Washington 18
Montréal 17
Zhengzhou 17
Addison 16
Poplar 16
Secaucus 16
Naples 15
Redwood City 15
San Salvador 15
Kunming 14
Lahore 14
Newark 14
Totale 16.701
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.268
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 423
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 341
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 324
Effects of vasoactive agents in healthy and diseased human saphenous veins 307
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 302
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 301
A new selective antagonist of the nociceptin receptor 298
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 297
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 296
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 294
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 288
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 286
A new ligand for the urotensin II receptor 284
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 276
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 274
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 272
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 267
Ala scan analogues of HOE 140. Synthesis and biological activities 267
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 259
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 258
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 256
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 254
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 252
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 251
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 249
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 248
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 243
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 242
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 242
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 241
Pharmacological characterisation of novel kinin B2 receptor ligands 240
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 239
Pharmacological characterization of tachykinin tetrabranched derivatives 237
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 235
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 234
B1 and B2 kinin receptors in various species 233
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 233
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 233
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 231
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 231
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 229
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 226
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 226
Pharmacological characterization of nociceptin receptor: an in vitro study 225
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 224
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 223
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 223
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 223
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 221
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 221
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 220
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 219
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 215
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 213
Structure-activity study at positions 3 and 4 of human neuropeptide S. 212
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 211
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 206
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 206
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 205
Characterization of the human vascular kinin B2 receptor by binding assays. 201
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 201
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 200
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 200
Structure-activity relationship study on human urotensin II 200
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 198
Nociceptin/orphanin FQ receptor ligands 193
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 188
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 188
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 186
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 184
Pharmacology of nociceptin and its receptor: a novel therapeutic target 183
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 183
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 180
Characterization of endothelin receptors in the human umbilical artery and vein 180
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 178
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 177
Pharmacology of the Kallikrein-Kinin system 176
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 174
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 173
Receptors for kinins in the human isolated umbilical vein 171
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 171
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 169
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 169
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 167
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 167
Endogenous nociceptin signaling and stress-induced analgesia 166
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 166
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 163
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 162
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 162
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 155
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 154
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 152
Characterization of the human vascular kinin B2 receptor by binding assays 150
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 149
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 149
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 149
Pharmacological profile of nociceptin/orphanin FQ receptors 143
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 139
Totale 23.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022868 0 0 0 0 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20267.583 849 329 619 1.013 1.132 476 892 377 707 719 320 150
2026/20273.492 1.285 399 716 842 250 0 0 0 0 0 0 0
Totale 24.662